Ultromics was founded in May 2017 at the University of Oxford by Ross Upton and Professor Paul Leeson.

While pursuing his PhD at the University of Oxford, Ross worked with Professor Leeson, Consultant Cardiologist and Head of the Oxford Cardiovascular Research Facility, to develop the world’s first outcomes-driven, AI-based ultrasonic diagnostic support solution for coronary artery disease (CAD).

During development, the team assembled and analyzed 120,000 echocardiographic images from clinical trials conducted at the University of Oxford. The team then tracked patient progress throughout the following year, collecting crucial longitudinal data specifying patient outcomes.

Recognizing the significance of this breakthrough, the American Society of Echocardiography named Ultromics a part of the 2018 “Echovation Honor Roll”.

Ultromics has attracted a team of clinicians, scientists, engineers, and healthcare professionals to develop, refine, and deliver our technology to market. A number of notable companies and individuals have also joined Ultromics as trusted partners.